Friday, April 03, 2020 11:36:52 PM
We currently have under 20 million shares outstanding. Solid news should make the company worthy of at least a half billion, but I believe a billion dollar market cap. If the O/S grows to 25 million, that's a $40 price for a billion dollar market cap, frankly if PLX-PAD were adopted for use in pneumonia, I believe the market cap would be well over $10 billion, even if it wasn't given until a patient was thought to need hospital care.
So many diseases ultimately kill when in a weakened state people get pneumonia. Common flu typically kills tens to hundreds of thousands annually, only about .1% of all who get the disease, but still a lot of people who'd survive if the pneumonia were cured.
Let's see what the evidence shows when we get data on many people who've taken the drug.
Gary
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM